← Open Payments lookup

COURTNEY FISCHER-BROWN: Open Payments

NPI 1457627945 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$347 in 17 payments from 9 companies in 2025. Trend: 2023 $420 · 2024 $267 · 2025 $347

Food & beverage: $347
CompanyPaymentsAmount
Amgen Inc.5$90
PFIZER INC.2$51
ABBVIE INC.2$50
Boehringer Ingelheim Pharmaceuticals, Inc.3$47
AstraZeneca Pharmaceuticals LP1$31
Lilly USA, LLC1$22
GlaxoSmithKline, LLC.1$20
Currax Pharmaceuticals LLC1$18
Novo Nordisk Inc1$18

Products named: REPATHA, PREVNAR 20, QULIPTA, JARDIANCE, FARXIGA, MOUNJARO, TRELEGY ELLIPTA, CONTRAVE.

Industry payments across TX — which companies pay providers there.